Literature DB >> 32565311

Ephrin-Eph signaling usage by a variety of viruses.

Esther C W de Boer1, Janine M van Gils2, Marit J van Gils3.   

Abstract

Ephrin-Eph signaling is a receptor tyrosine kinase signaling pathway involved in a variety of cellular mechanisms, of which many are related to the adhesion or migration of cells. Both the Eph receptor and ephrin ligand are abundantly present on a wide variety of cell types, and strongly evolutionary conserved. This review provides an overview of how 18 genetically diverse viruses utilize the Eph receptor (Eph), ephrin ligand (ephrin) or ephrin-Eph signaling to their advantage in their viral life cycle. Both Ephs and ephrins have been shown to serve as entry receptors for a variety of viruses, via both membrane fusion and endocytosis. Ephs and ephrins are also involved in viral transmission by vectors, associated with viral replication or persistence and lastly to neurological damage caused by viral infection. Although therapeutic opportunities targeting Ephs or ephrins do not seem feasible yet, the current research does propose two models for the viral usage of ephrin-Eph signaling. Firstly, the viral entry model, in which membrane molecules are used for viral entry, leading to cells being used for replication or as a transporter. Secondly, the advantageous expression ephrin-Eph signaling model, where viruses adapt the expression of Ephs or ephrins to change cell-cell interaction to their advantage. These models can guide future research questions on the usage of Ephs or ephrins by viruses and therapeutic opportunities.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Chloroquine (Pubchem CID: 2719); Dasatinib (Pubchem CID: 3062316); Ephrin-Eph signaling; Henipavirus; Lymphocyte migration; Nicotine (Pubchem CID: 89594); Tyrosine kinase; Viral entry; Virus infection

Mesh:

Substances:

Year:  2020        PMID: 32565311     DOI: 10.1016/j.phrs.2020.105038

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility.

Authors:  Marwah M Al-Mathkour; Abdulrahman M Dwead; Esma Alp; Ava M Boston; Bekir Cinar
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

2.  In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling.

Authors:  Arnaud Germain; Susan M Levine; Maureen R Hanson
Journal:  Proteomes       Date:  2021-01-29

3.  Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases.

Authors:  Hamidreza Zalpoor; Abdullatif Akbari; Mohsen Nabi-Afjadi
Journal:  Hum Cell       Date:  2022-04-04       Impact factor: 4.374

4.  Serotype I and II Feline Coronavirus Replication and Gene Expression Patterns of Feline Cells-Building a Better Understanding of Serotype I FIPV Biology.

Authors:  Sarah Cook; Diego Castillo; Sonyia Williams; Christine Haake; Brian Murphy
Journal:  Viruses       Date:  2022-06-22       Impact factor: 5.818

Review 5.  The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.

Authors:  Hamidreza Zalpoor; Abdullatif Akbari; Azam Samei; Razieh Forghaniesfidvajani; Monireh Kamali; Azadeh Afzalnia; Shirin Manshouri; Fatemeh Heidari; Majid Pornour; Majid Khoshmirsafa; Hossein Aazami; Farhad Seif
Journal:  Cell Mol Biol Lett       Date:  2022-02-02       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.